Rigel Pharmaceuticals, Inc.
シンボルマーク: RIGL
NASDAQ
1.1
USD今日の市場価格
-7.4054
PER(株価収益率
3.7767
PEGレシオ
192.92M
MRK キャップ
- 0.00%
DIV利回り
Rigel Pharmaceuticals, Inc. (RIGL) 財務諸表
貸借対照表
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 242.3 | 56.9 | 58.2 | 125 | |||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 75.01 | 24.1 | 33.7 | 106.1 | |||||||||||||||||||||||||
balance-sheet.row.net-receivables | 104.28 | 30.6 | 40.3 | 15.5 | |||||||||||||||||||||||||
balance-sheet.row.inventory | 33.49 | 5.5 | 9.1 | 6.6 | |||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 22.11 | 6.3 | 8.3 | 7.4 | |||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 402.19 | 99.3 | 115.9 | 154.5 | |||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 4.85 | 1 | 2.8 | 11.9 | |||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 57.12 | 13.9 | 14.9 | 0 | |||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 57.12 | 13.9 | 14.9 | 0 | |||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 9.09 | 3.1 | 0.6 | 1 | |||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 71.06 | 18 | 18.4 | 12.9 | |||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.total-assets | 473.25 | 117.2 | 134.3 | 167.3 | |||||||||||||||||||||||||
balance-sheet.row.account-payables | 26.68 | 7.1 | 22.5 | 3.8 | |||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 9.51 | 7.9 | 1.1 | 9.9 | |||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 233.27 | 52.7 | 40.4 | 20.7 | |||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 119.69 | 21.2 | 28.1 | 47.3 | |||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 395.02 | 92.6 | 82.7 | 73.4 | |||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 4.46 | 1 | 2.1 | 10.7 | |||||||||||||||||||||||||
balance-sheet.row.total-liab | 586.1 | 145.9 | 147.9 | 137 | |||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.common-stock | 0.7 | 0.2 | 0.2 | 0.2 | |||||||||||||||||||||||||
balance-sheet.row.retained-earnings | -5614.43 | -1407.5 | -1382.5 | -1323.9 | |||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -0.06 | 0 | -0.2 | -0.1 | |||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 5500.94 | 1378.7 | 1368.8 | 1354.2 | |||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | -112.85 | -28.6 | -13.6 | 30.4 | |||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 473.25 | 117.2 | 134.3 | 167.3 | |||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
balance-sheet.row.total-equity | -112.85 | -28.6 | -13.6 | 30.4 | |||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 473.25 | - | - | - | |||||||||||||||||||||||||
Total Investments | 75.01 | 24.1 | 33.7 | 106.1 | |||||||||||||||||||||||||
balance-sheet.row.total-debt | 242.78 | 60.6 | 41.6 | 30.6 | |||||||||||||||||||||||||
balance-sheet.row.net-debt | 75.48 | 27.8 | 17.1 | 11.7 |
キャッシュフロー計算書
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -25.09 | -25.1 | -58.6 | -17.9 | |||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 1.24 | 1.2 | 1 | 1.2 | |||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 3.99 | -10.6 | 0 | 0.3 | |||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 8.81 | 8.8 | 12.4 | 9.5 | |||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 9.52 | 9.5 | -29 | 9.7 | |||||||||||||||||||||||||
cash-flows.row.account-receivables | 9.77 | 9.8 | -24.8 | 0.5 | |||||||||||||||||||||||||
cash-flows.row.inventory | 1.17 | 1.2 | -2.4 | -4.9 | |||||||||||||||||||||||||
cash-flows.row.account-payables | -0.37 | -0.4 | 3.8 | 0 | |||||||||||||||||||||||||
cash-flows.row.other-working-capital | -1.06 | -1.1 | -5.6 | 14.1 | |||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | -4.21 | 10.4 | 0.5 | 3.1 | |||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -5.74 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -15.13 | -15 | -0.5 | -0.6 | |||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0.26 | 0.3 | 0.9 | 0.6 | |||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -31.33 | -31.2 | -28.9 | -141.5 | |||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 41.65 | 41.6 | 101.2 | 62 | |||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 3.23 | 0 | 0 | -0.6 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -4.3 | -4.3 | 72.8 | -80 | |||||||||||||||||||||||||
cash-flows.row.debt-repayment | -20.93 | -17.3 | -4.4 | -57.9 | |||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 1.05 | 1 | 2.1 | 4.8 | |||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 36.93 | 34.6 | 8.9 | 115.8 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 18.37 | 18.4 | 6.5 | 62.7 | |||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -1.01 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 8.33 | 8.3 | 5.6 | -11.5 | |||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 167.3 | 32.8 | 24.5 | 18.9 | |||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 158.97 | 24.5 | 18.9 | 30.4 | |||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | -5.74 | -5.7 | -73.8 | 5.9 | |||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -15.13 | -15 | -0.5 | -0.6 | |||||||||||||||||||||||||
cash-flows.row.free-cash-flow | -20.88 | -20.7 | -74.2 | 5.3 |
損益計算書の行
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 116.88 | 116.9 | 120.2 | 149.2 | |||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 7.11 | 7.1 | 1.7 | 1.1 | |||||||||||||||||||||||||
income-statement-row.row.gross-profit | 109.77 | 109.8 | 118.5 | 148.2 | |||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||
income-statement-row.row.research-development | 24.52 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 26.31 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 1.3 | 3.5 | |||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 130.26 | 130.3 | 172.7 | 157.1 | |||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 137.37 | 137.4 | 174.5 | 158.2 | |||||||||||||||||||||||||
income-statement-row.row.interest-income | 2.27 | 2.3 | 0.7 | 0 | |||||||||||||||||||||||||
income-statement-row.row.interest-expense | 6.87 | 6.9 | 3.7 | 4.9 | |||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -4.6 | -4.6 | -4.3 | -8.3 | |||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 1.3 | 3.5 | |||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -4.6 | -4.6 | -4.3 | -8.3 | |||||||||||||||||||||||||
income-statement-row.row.interest-expense | 6.87 | 6.9 | 3.7 | 4.9 | |||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 1.63 | 1.2 | 0.7 | 0 | |||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | -17.28 | - | - | - | |||||||||||||||||||||||||
income-statement-row.row.operating-income | -20.49 | -20.5 | -54.2 | -9 | |||||||||||||||||||||||||
income-statement-row.row.income-before-tax | -25.09 | -25.1 | -58.6 | -17.3 | |||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 2.39 | 2.3 | 3 | 0.6 | |||||||||||||||||||||||||
income-statement-row.row.net-income | -25.9 | -25.1 | -61.6 | -17.9 |
よくある質問
Rigel Pharmaceuticals, Inc.RIGL 総資産とは何ですか?
Rigel Pharmaceuticals, Inc. (RIGL) 総資産は 117225000.000.
企業の年間売上高とは?
年間収益は 63926000.000である.
企業の利益率は?
利益率は 0.939 である.
企業のフリーキャッシュフローとは?
フリーキャッシュフローは -0.120.
企業の純利益率は?
純利益率は -0.222 である.
企業の総収入は?
総収入は -0.175 である.
Rigel Pharmaceuticals, Inc. (RIGL) 純利益(純利益)とは何ですか?
純利益(純利益)は -25091000.000.
負債総額は?
負債合計は 60579000.000 である.
営業費用はいくらですか?
営業費用は 130263000.000 である.
会社の現金はいくらですか?
企業の現金は 32786000.000 である.